Allianz Biotechnologie
Country/Region
North America
Sector
Biotechnologie
Performance (1Y)
25.64%
Total expense ratio (TER)
2.05 %
Investment fund volume
251,384,647
Appropration of income
Distribution
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE | 216.16 G | 0 Units |
| PRICE DETERMINATION TIME | 06/08/2026 / 09:56:08 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 221.22 | 215.6 |
| PREV. DAY'S PRICE | 220.04 | (06/05) |
| CHANGE DAY BEFORE | -3.88 | -1.76 % |
| 52 WEEK HIGH / LOW | 239.96 (11/28) | 171.84 (06/26) |
Master Data
| WKN | 848186 |
| ISIN | DE0008481862 |
| SYMBOL | DJFF |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Fund |
| MANAGEMENT TYPE | Active |
| INVESTMENT FUND TYPE | Equity Fund |
| PRODUCT DENOMINATION | Allianz Biotechnologie |
| MARKET MAKER | - |
| COUNTRY/REGION | North America |
| ISSUER/INVESTMENT COMPANY | Allianz Global Investors Europe GmbH |
| MAPPED INDEX/BENCHMARK | NASDAQ Biotechnology Index |
| INDUSTRY | Biotechnologie |
| FUND CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| DISTRIBUTION | Distribution |
| TER | 2.05 % |
| LISTING DATE | 21/05/2007 |
| INVESTMENT FUND VOLUME | 251,384,646.62 |
| END OF FINANCIAL YEAR | 31/12/2025 |
| LICENSED FOR SALE IN GERMANY | Yes |
| TRADING HOURS | 07:30 - 22:00 |
| QUOTATION | continuous auction |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.47 % | -0.92 % | -2.20 % | -5.33 % | 25.64 % | 7.41 % | 9.86 % | -4.71 % |
| HIGH | 226.70 | 228.34 | 231.66 | 236.56 | 239.96 | 239.96 | 243.44 | 236.56 |
| LOW | 214.22 | 214.22 | 214.22 | 214.22 | 171.84 | 155.50 | 155.50 | 214.22 |
Investment strategy
Description
Der Fonds investiert in Aktien von Unternehmen, die ueberwiegend im Bereich der biotechnologischen Forschung, Entwicklung oder Produktion taetig sind. Anlageziel ist langfristiger, ueberdurchschnittlicher Kapitalzuwachs.